Metoprolol Tartrate Tablets — Class II drug recall D-0362-2022
Terminated recall by Rubicon Research Private Limited, reported 2022-01-19, distributed nationwide. Complaint received of foreign matter (metal) embedded in tablet.
| Recall number | D-0362-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Rubicon Research Private Limited, Ambernath, N/A, India |
| Recall initiated | 2021-12-31 |
| Classified | 2022-01-07 |
| Reported by FDA | 2022-01-19 |
| Terminated | 2022-11-04 |
| Distributed | Nationwide (US) |
| Reason classes | foreign material |
| NDC | 52817-0358, 52817-0358-10, 52817-0358-50, 52817-0359, 52817-0359-10, 52817-0359-50, 52817-0360, 52817-0360-00, 52817-0360-10, 52817-0361, 52817-0361-00, 52817-0361-10, 52817-0362, 52817-0362-00, 52817-0362-10 |
| Lot numbers | 210211H1 |
| Expiration dates | 2024-02-20 |
Product
Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; Manufactured by: Rubicon Research Prvate Limited Ambernath, Dist. Thane, 421506 India. NDC 52817-360-00
Reason for recall
Complaint received of foreign matter (metal) embedded in tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0362-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.